Literature DB >> 8518521

Neurological manifestations of hemorrhagic colitis in the outbreak of Escherichia coli O157:H7 infection in Japan.

S Hamano1, Y Nakanishi, T Nara, T Seki, T Ohtani, T Oishi, K Joh, T Oikawa, Y Muramatsu, Y Ogawa.   

Abstract

An outbreak of hemorrhagic colitis associated with Escherichia coli O157:H7 occurred in a kindergarten in Saitama, Japan from September to November, 1990. Seven patients admitted to our hospital showed neurological manifestations: generalized seizures, impaired consciousness, urinary incontinence, gaze nystagmus, phrenic nerve palsy, action tremor and vertigo. Two patients died. On the basis of the clinical courses and laboratory findings of the seven patients and postmortem findings of one case, these neurological symptoms were suspected to be induced by the verotoxin elaborated by Escherichia coli O157:H7.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8518521     DOI: 10.1111/j.1651-2227.1993.tb12721.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  21 in total

1.  Bidirectional concentration-dependent effects of tumor necrosis factor alpha in Shigella dysenteriae-related seizures.

Authors:  Yael Yuhas; Abraham Weizman; Shai Ashkenazi
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

2.  Encephalopathy and exposure to Shiga toxin without evidence of haemolytic uraemic syndrome.

Authors:  Frank Ahrens; Kerstin Ludwig; Klaus Terstegge; Uwe Querfeld
Journal:  Eur J Pediatr       Date:  2002-08       Impact factor: 3.183

Review 3.  Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion.

Authors:  C L Sears; J B Kaper
Journal:  Microbiol Rev       Date:  1996-03

Review 4.  Chronic sequelae of E. coli O157: systematic review and meta-analysis of the proportion of E. coli O157 cases that develop chronic sequelae.

Authors:  Jessica Keithlin; Jan Sargeant; M Kate Thomas; Aamir Fazil
Journal:  Foodborne Pathog Dis       Date:  2013-11-27       Impact factor: 3.171

5.  Rapid apoptosis induced by Shiga toxin in HeLa cells.

Authors:  Jun Fujii; Takashi Matsui; Daniel P Heatherly; Kailo H Schlegel; Peter I Lobo; Takashi Yutsudo; Georgianne M Ciraolo; Randal E Morris; Tom Obrig
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

6.  Role of nitric oxide in the enhancement of pentylenetetrazole-induced seizures caused by Shigella dysenteriae.

Authors:  J Balter-Seri; Y Yuhas; A Weizman; Y Nofech-Mozes; E Kaminsky; S Ashkenazi
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

7.  Pathogenic mechanism of mouse brain damage caused by oral infection with Shiga toxin-producing Escherichia coli O157:H7.

Authors:  E Kita; Y Yunou; T Kurioka; H Harada; S Yoshikawa; K Mikasa; N Higashi
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

Review 8.  Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome.

Authors:  Saul Tzipori; Abhineet Sheoran; Donna Akiyoshi; Arthur Donohue-Rolfe; Howard Trachtman
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

9.  Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice.

Authors:  J Fujii; T Kita; S Yoshida; T Takeda; H Kobayashi; N Tanaka; K Ohsato; Y Mizuguchi
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

10.  Cerebral magnetic resonance imaging findings in adults with haemolytic uraemic syndrome following an infection with Escherichia coli, subtype O104:H4.

Authors:  U Löbel; B Eckert; O Simova; M Meier-Cillien; S Kluge; C Gerloff; J Röther; T Magnus; J Fiehler
Journal:  Clin Neuroradiol       Date:  2013-06-29       Impact factor: 3.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.